MAGE-A1
MAGE-A1 | ||
---|---|---|
![]() |
||
according to PDB 3BO8 | ||
other names |
|
|
Properties of human protein | ||
Mass / length primary structure | 34,342 Da / 309 amino acids | |
Identifier | ||
Gene name | MAGEA1 | |
External IDs | ||
Occurrence | ||
Homology family | HOG000231161 |
MAGE-A1 ( English melanoma antigen A3 ) is a human tumor antigen from the group of the cancer testis antigens .
properties
MAGE-A1 is 309 amino acids in length and 34,342 Da in mass . It has a poly serine tract from position 32 to 36. MAGE-A1 comes as a tumor antigen not in healthy cells before (except in immune privileged spermatocytes ), but often in different tumors expressed . It is therefore a target antigen in the development of cancer vaccines and cancer immunotherapies with adoptive cell transfer .
Individual evidence
- ↑ DK Krishnadas, F. Bai, KG Lucas: Cancer testis antigen and immunotherapy. In: ImmunoTargets and therapy. Volume 2, 2013, pp. 11-19, doi: 10.2147 / ITT.S35570 , PMID 27471684 , PMC 4928360 (free full text).
- ↑ M. Tagliamonte, A. Petrizzo, ML Tornesello, FM Buonaguro, L. Buonaguro: Antigen-specific vaccines for cancer treatment. In: Human vaccines & immunotherapeutics. Volume 10, number 11, 2014, pp. 3332–3346, doi: 10.4161 / 21645515.2014.973317 , PMID 25483639 , PMC 4514024 (free full text).